INR 5.24
(0.0%)
Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|---|
Operating Cash Flow | 7.45 Million | -99.98 Million | 75.4 Million | 27.44 Million | -62.78 Million | -46.17 Million |
Net Income | -271.1 Million | -117.81 Million | 523 Thousand | -6.48 Million | 2.28 Million | 3.29 Million |
Depreciation & Amortization | 14.61 Million | 15.8 Million | 16.39 Million | 18.35 Million | 20.6 Million | 9.62 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | 264.93 Million | -26.13 Million | 34.31 Million | -17.98 Million | -106.8 Million | -59.09 Million |
Other non-cash items | -242.06 Million | 28.15 Million | 24.16 Million | 33.56 Million | 21.12 Million | 78.45 Million |
Investing Cash Flow | - | -4.05 Million | -503 Thousand | 1.99 Million | -3.56 Million | 1.66 Million |
Investments in PPE | - | -3.95 Million | -1.86 Million | -372 Thousand | -1.48 Million | - |
Acquisitions | - | - | - | - | - | 1.66 Million |
Investment purchases | - | - | - | - | -3.57 Million | - |
Sales/Maturities of investments | - | - | - | 1.51 Million | - | - |
Other Investing Activities | - | -105 Thousand | 1.36 Million | 849.31 Thousand | 1.48 Million | - |
Financing Cash Flow | -7.93 Million | 104.41 Million | -78.67 Million | -59.4 Million | 72.78 Million | 33.23 Million |
Debt repayment | -7.93 Million | -132.57 Million | -51.77 Million | -24.53 Million | -93.18 Million | -200.51 Thousand |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | - | 236.98 Million | -26.9 Million | -34.86 Million | 165.96 Million | 33.44 Million |
Accounts receivables | 191.42 Million | -18.33 Million | 86.41 Million | 119.52 Million | -52.75 Million | -136.24 Million |
Accounts payables | 21.42 Million | 46.65 Million | -53.54 Million | -100.62 Million | -14.21 Million | 81.4 Million |
Inventory | 57.46 Million | 88.58 Million | 8.06 Million | -27.28 Million | -39.83 Million | -4.25 Million |
Other working capital | -5.37 Million | -143.03 Million | -6.61 Million | -9.59 Million | - | - |
Cash at beginning of period | 1.05 Million | 690 Thousand | 4.46 Million | 34.42 Million | 27.99 Million | 39.27 Million |
Cash at end of period | 577 Thousand | 1.05 Million | 690 Thousand | 4.46 Million | 34.42 Million | 27.99 Million |
Capital Expenditure | - | -3.95 Million | -1.86 Million | -372 Thousand | -1.48 Million | - |
Effect of forex changes on cash | - | - | 1000.00 | - | - | - |
Net cash flow / Change in cash | -482 Thousand | 369 Thousand | -3.77 Million | -29.96 Million | 6.42 Million | -11.27 Million |
Free Cash Flow | 7.45 Million | -103.93 Million | 73.53 Million | 27.07 Million | -64.27 Million | -46.17 Million |
Breakdown | 2023 FY | 2023 Q2 | 2023 Q1 | 2022 FY | 2022 Q4 | 2022 Q3 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | -271.1 Million | -1.08 Million | -14.89 Million | -117.81 Million | -89.07 Million | -13.46 Million |
Depreciation & Amortization | 14.61 Million | 3.65 Million | 3.65 Million | 15.8 Million | 8.05 Million | 4.04 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | 264.93 Million | - | - | -26.13 Million | - | - |
Other non-cash items | -242.06 Million | -3.65 Million | -3.65 Million | 28.15 Million | -8.05 Million | -4.04 Million |
Investing Cash Flow | - | - | - | -4.05 Million | - | - |
Investments in PPE | - | - | - | -3.95 Million | - | - |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | - | - | - | -105 Thousand | - | - |
Financing Cash Flow | -7.93 Million | - | - | 104.41 Million | - | - |
Debt repayment | -7.93 Million | - | - | -132.57 Million | - | - |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | - | - | - | 236.98 Million | - | - |
Accounts receivables | 191.42 Million | - | - | -18.33 Million | - | - |
Accounts payables | 21.42 Million | - | - | 46.65 Million | - | - |
Inventory | 57.46 Million | - | - | 88.58 Million | - | - |
Other working capital | -5.37 Million | - | - | -143.03 Million | - | - |
Cash at beginning of period | 1.05 Million | 1.94 Million | 1.05 Million | 690 Thousand | 90.13 Million | 2.17 Million |
Cash at end of period | 577 Thousand | 858 Thousand | -14.89 Million | 1.05 Million | 1.05 Million | -13.46 Million |
Capital Expenditure | - | - | - | -3.95 Million | - | - |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | -482 Thousand | -1.08 Million | -15.95 Million | 369 Thousand | -89.07 Million | -15.64 Million |
Free Cash Flow | 7.45 Million | -1.08 Million | -14.89 Million | -103.93 Million | -89.07 Million | -13.46 Million |
ESPE
GYST
600017
BLGO
MGRT
NLCP